Hormone-Refractory Prostate Cancer Completed Phase 3 Trials for Radium Ra 223 dichloride (DB08913)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00699751A Phase III Study of Radium-223 Dichloride in Patients With Symptomatic Hormone Refractory Prostate Cancer With Skeletal MetastasesTreatment